A Multicenter, Randomized, Blinded, Placebo-Controlled Study To Evaluate The Safety Of Maraviroc In Combination With Other Antiretroviral Agents In HIV-1-Infected Subjects Co-Infected With Hepatitis C And/Or Hepatitis B Virus
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2015
At a glance
- Drugs Maraviroc (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors ViiV Healthcare
- 07 Jun 2017 Biomarkers information updated
- 28 Apr 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 09 Oct 2012 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.